Globus Medical, Inc. Class A (GMED) Q1 2025 Earnings Call

Investor webinar replay

Watch the replay and follow the connected company analysis, news, and investor updates for Globus Medical, Inc..

Watch the replay

Replay transcript excerpt

WEBVTT 00:00:00.031 -- 00:00:03.795 and a Q&A session will be held after the prepared remarks. 00:00:03.795 -- 00:00:08.281 To ask a question during the session, you will need to press star 11 on your telephone. 00:00:08.281 -- 00:00:11.865 You will then hear an automated message advising your hand is raised. 00:00:11.865 -- 00:00:14.989 To withdraw your question, please press star 11 again. 00:00:14.989 -- 00:00:20.355 I will now turn the call over to Brian Kearns, Senior Vice President of Business Development 00:00:20.355 -- 00:00:25.539 and Investor Relations. Mr. Kearns, please go ahead. 00:00:25.721 -- 00:00:29.225 Thank you, Brianna, and thank you, everyone, for being with us today. 00:00:29.225 -- 00:00:34.250 Joining today's call from Globus Medical will be Dan Scavilla, President and CEO, and 00:00:34.250 -- 00:00:38.835 Keith Feil, Chief Operating Officer and Chief Financial Officer. 00:00:38.835 -- 00:00:42.959 This review is being made available via webcast, accessible through the investor relations 00:00:42.959 -- 00:00:46.941 section of the Globus Medical website at globusmedical.com. 00:00:47.063 -- 00:00:51.047 Before we begin, let me remind you that some of the statements made during this review 00:00:51.047 -- 00:00:55.292 are or may be considered forward-looking statements. 00:00:55.292 -- 00:01:00.339 Our Form 10-K for the 2024 fiscal year and our subsequent filings 00:01:00.339 -- 00:01:04.905 with the Securities and Exchange Commission identify certain factors that could cause 00:01:04.905 -- 00:01:09.692 our actual results to differ materially from those projected in any forward-looking statements 00:01:09.692 -- 00:01:11.394 made today. 00:01:11.394 -- 00:01:17.022 Our SEC filings, including the 10-K, are available on our website. 00:01:17.022...